While in many B-cell malignancies, the activation of the BCR-signaling pathway occurs via genetic activation of signaling mediators16,17 or by BCR mimicry18,19, the BCRs expressed by CLL cells frequently recognize autoantigens, including an internal epitope of their own BCR5. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.